CICécile Ingueneau

Cécile Ingueneau

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Cécile Ingueneau has a total of 50 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • A reference measurement of circulating ATPase inhibitory factor 1 (IF1) in humans by LC-MS/MS: Comparison with conventional ELISA

    by Annelise Genoux, Thibaut Duparc, Jean-Bernard Ruidavets, Cécile Ingueneau, Souad Najib, Jean Ferrières, Bertrand Perret, Mikaël Croyal, Laurent O. Martinez


  • Open Access

    A reference measurement of circulating ATPase inhibitory factor 1 (IF1) in humans by LC-MS/MS: comparison with conventional ELISA

    by Annelise Genoux, Thibaut Duparc, Jean-Bernard Ruidavets, Cecile Ingueneau, Souad Najib, Jean Ferrieres, Bertrand Perret, Mikael Croyal, Laurent O Martinez

    ATPase inhibitory factor 1 (IF1) is a 9.5 kDa protein that binds to mitochondrial and plasma membrane ATP synthase and selectively inhibits ATP hydrolysis. Recently, IF1 was identified in systemic circulation in humans. IF1 appeared as an independent determinant of HDL-cholesterol with lower levels in coronary heart disease (CHD) patients. Moreover, IF1 was also found to negatively associate with mortality in these patients, supporting the notion that circulating IF1 could be a promising biomarker of cardiovascular disease. However, in previous studies, IF1 was quantified by a non-standardized competitive enzyme-linked immunosorbent assay (ELISA). Herein, we have validated a liquid chromatography-tandem mass spectrometry method (LC-MS/MS) enabling the accurate quantification of IF1 in human plasma. Plasma IF1 was trypsin-digested through an optimized procedure before LC-MS/MS analysis. The method was successfully validated over 4 independent experiments into the range of 100-1,500 ng/mL. Intra- and inter-assay variation coefficients had never exceeded 14.2% and accuracy ranged between 95% and 102% for the selected EAGGAFGK peptide marker. Subsequently, the results of the LC-MS/MS method were compared with those obtained using ELISA in 204 individuals from the GENES study. We found that IF1 plasma levels obtained using both techniques were strongly correlated (r =0.89, p <0.0001), while the Bland-Altman plot did not indicate any major statistically significant differences. To clinically validate LC-MS/MS, we confirmed the positive correlation between IF1 plasma levels and HDL-cholesterol (r =0.38, p <0.0001). Besides, we found lower IF1 plasma levels in CHD patients compared to controls (431 +/- 132 ng/mL and 555 +/- 173 ng/mL, respectively; p <0.0001). Hence, it can be concluded that the presented LC-MS/MS method provides a highly specific strategy for IF1 quantification in human plasma and could be proposed as a reference technique.

  • Open Access

    Serum level of High-density lipoprotein particles are independently associated with long-term prognosis in patients with coronary artery disease: The GENES study

    by Thibaut Duparc, Jean-Bernard Ruidavets, Annelise Genoux, Cécile Ingueneau, Souad Najib, Jean Ferrieres, Bertrand Perret, Laurent O. Martinez

    Background HDL-Cholesterol (HDL-C) is not a right marker to measure the cardioprotective functions of HDL in coronary artery diseases (CAD) patients. Hence, measurement of other HDL-related parameters may have prognostic superiority over HDL-C. This work aimed to examine the predictive value of HDL particles profile for long-term mortality in CAD patients. Its informative value was compared to that of HDL-C and apoA-I. Method NMR spectroscopy HDL particles profile were measured by nuclear magnetic resonance (NMR) spectroscopy in 214 male participants with stable CAD (age 45-74 years). Vital status was yearly assessed, with a median follow up of 12.5 years and a 36.4% mortality rate. Cardiovascular mortality accounted for the majority (64.5 %) of deaths. Results Mean concentrations of HDL particles (HDL-P), small and medium-sized HDL (MS-HDL) and apoA-I were lower in deceased than in surviving patients whereas no difference was observed according to HDL-C and large HDL particles. All NMR-HDL measures were correlated between themselves and with other HDL markers (HDL-C, apoA-I and LpA-I). In a multivariate model adjusted for 14 cardiovascular risk factors and bioclinical variables, HDL-P and MS-HDL-P displayed the strongest inverse association with all-cause and cardiovascular mortality. Weaker associations were recorded for apoA-I. Conclusions HDL particle profile measured by NMR spectroscopy should be considered to better stratify risk in population at high risk or in the setting of pharmacotherapy.

  • Impact of micronutrient deficiency & malnutrition in systemic sclerosis: Cohort study and literature review

    by Romain Dupont, Mélanie Longué, Anne Galinier, Christel Cinq Frais, Cécile Ingueneau, Léonardo Astudillo, Philippe Arlet, Daniel Adoue, Laurent Alric, Grégoire Prévot, et al.


  • High-density lipoprotein subclass profile and mortality in patients with coronary artery disease: Results from the GENES study

    by Meyer Elbaz, Julien Faccini, Vanina Bongard, Cécile Ingueneau, Dorotea Taraszkiewicz, Bertrand Perret, Jean Ferrières, Jean-Bernard Ruidavets, Cécile Vindis


  • Open Access

    Role of protein kinase C δ in ER stress and apoptosis induced by oxidized LDL in human vascular smooth muscle cells

    by P Larroque-Cardoso, A Swiader, C Ingueneau, A Nègre-Salvayre, M Elbaz, M E Reyland, R Salvayre, C Vindis

    During atherogenesis, excess amounts of low-density lipoproteins (LDL) accumulate in the subendothelial space where they undergo oxidative modifications. Oxidized LDL (oxLDL) alter the fragile balance between survival and death of vascular smooth muscle cells (VSMC) thereby leading to plaque instability and finally to atherothrombotic events. As protein kinase C δ (PKCδ) is pro-apoptotic in many cell types, we investigated its potential role in the regulation of VSMC apoptosis induced by oxLDL. We found that human VSMC silenced for PKCδ exhibited a protection towards oxLDL-induced apoptosis. OxLDL triggered the activation of PKCδ as shown by its phosphorylation and nuclear translocation. PKCδ activation was dependent on the reactive oxygen species generated by oxLDL. Moreover, we demonstrated that PKCδ participates in oxLDL-induced endoplasmic reticulum (ER) stress-dependent apoptotic signaling mainly through the IRE1α/JNK pathway. Finally, the role of PKCδ in the development of atherosclerosis was supported by immunohistological analyses showing the colocalization of activated PKCδ with ER stress and lipid peroxidation markers in human atherosclerotic lesions. These findings highlight a role for PKCδ as a key regulator of oxLDL-induced ER stress-mediated apoptosis in VSMC, which may contribute to atherosclerotic plaque instability and rupture.


  • Open Access

    TRPC1 is regulated by caveolin‐1 and is involved in oxidized LDL‐induced apoptosis of vascular smooth muscle cells

    by Cécile Ingueneau, Uyen Huynh‐Do, Bertrand Marcheix, Anne Athias, Philippe Gambert, Anne Nègre‐Salvayre, Robert Salvayre, Cécile Vindis

    Oxidized low‐density lipoprotein (oxLDL) induced‐apoptosis of vascular cells may participate in plaque instability and rupture. We have previously shown that vascular smooth muscle cells (VSMC) stably expressing caveolin‐1 were more susceptible to oxLDL‐induced apoptosis than VSMC expressing lower level of caveolin‐1, and this was correlated with enhanced Ca2+ entry and pro‐apoptotic events. In this study, we aimed to identify the molecular events involved in oxLDL‐induced Ca2+ influx and their regulation by the structural protein caveolin‐1. In VSMC, transient receptor potential canonical‐1 (TRPC1) silencing by ARN interference prevents the Ca2+ influx and reduces the toxicity induced by oxLDL. Moreover, caveolin‐1 silencing induces concomitant decrease of TRPC1 expression and reduces oxLDL‐induced apoptosis of VSMC. OxLDL enhanced the cell surface expression of TRPC1, as shown by biotinylation of cell surface proteins, and induced TRPC1 translocation into caveolar compartment, as assessed by subcellular fractionation. OxLDL‐induced TRPC1 translocation was dependent on actin cytoskeleton and associated with a dramatic rise of 7‐ketocholesterol (a major oxysterol in oxLDL) into caveolar membranes, whereas the caveolar content of cholesterol was unchanged. Altogether, the reported results show that TRPC1 channels play a role in Ca2+ influx and Ca2+ homeostasis deregulation that mediate apoptosis induced by oxLDL. These data also shed new light on the role of caveolin‐1 and caveolar compartment as important regulators of TRPC1 trafficking to the plasma membrane and apoptotic processes that play a major role in atherosclerosis.


  • Caveolin-1 sensitizes vascular smooth muscle cells to mildly oxidized LDL-induced apoptosis

    by Cécile Ingueneau, Uyen Huynh-Do, Jean-Claude Thiers, Anne Nègre-Salvayre, Robert Salvayre, Cécile Vindis


  • Oxygen-regulated protein-150 prevents calcium homeostasis deregulation and apoptosis induced by oxidized LDL in vascular cells

    by M Sanson, C Ingueneau, C Vindis, J-C Thiers, Y Glock, H Rousseau, Y Sawa, Y Bando, Z Mallat, R Salvayre, et al.

    Oxidized LDLs (oxLDLs) induce apoptosis, which contributes to the pathogenesis of atherosclerosis. The 150 kDa oxygen-regulated protein (ORP150), an endoplasmic reticulum (ER)-resident chaperone, is upregulated by hypoxia and prevents ischemia-induced cell death. The aim of this work was to investigate whether and how ORP150 can prevent apoptosis induced by oxLDLs in vascular cells. OxLDLs induced ORP150 expression in the ER of human microvascular endothelial cell line (HMEC-1). ORP150 expression was blocked by antioxidants, by the permeant calcium chelator BAPTA-AM, and by inhibitors of the inositol-1,4,5 trisphosphate (IP3) receptors, 2-aminoethyl diphenylborinate (2-APB) and xestospongin C. ORP150 silencing by siRNA-enhanced oxLDL-induced apoptosis, while forced ORP150 expression increased the resistance of cells via an inhibition of the oxLDL-induced calcium rise, and of subsequent calpain activation, cytochrome c release, caspase 3 activation and apoptosis. A similar protective effect was achieved by BAPTA-AM, 2-APB and xestospongin C. Altogether, these data indicate that (i)ORP150 inhibits oxLDL-induced apoptosis by blocking calcium signaling and subsequent apoptosis, (ii)calcium released from ER stores through IP3 channels is involved in the oxLDL-induced calcium rise and apoptosis, and is inhibited by ORP150. Finally, ORP150 is expressed in advanced atherosclerotic lesions, where it may locally participate to reduce the apoptotic effect of oxLDLs and the subsequent risk of plaque rupture.


  • Top Cited Papers

    Advanced lipid peroxidation end products in oxidative damage to proteins. Potential role in diseases and therapeutic prospects for the inhibitors

    by A Negre‐Salvayre, C Coatrieux, C Ingueneau, R Salvayre

    Reactive carbonyl compounds (RCCs) formed during lipid peroxidation and sugar glycoxidation, namely Advanced lipid peroxidation end products (ALEs) and Advanced Glycation end products (AGEs), accumulate with ageing and oxidative stress‐related diseases, such as atherosclerosis, diabetes or neurodegenerative diseases. RCCs induce the ‘carbonyl stress’ characterized by the formation of adducts and cross‐links on proteins, which progressively leads to impaired protein function and damages in all tissues, and pathological consequences including cell dysfunction, inflammatory response and apoptosis. The prevention of carbonyl stress involves the use of free radical scavengers and antioxidants that prevent the generation of lipid peroxidation products, but are inefficient on pre‐formed RCCs. Conversely, carbonyl scavengers prevent carbonyl stress by inhibiting the formation of protein cross‐links. While a large variety of AGE inhibitors has been developed, only few carbonyl scavengers have been tested on ALE‐mediated effects. This review summarizes the signalling properties of ALEs and ALE‐precursors, their role in the pathogenesis of oxidative stress‐associated diseases, and the different agents efficient in neutralizing ALEs effectsin vitroandin vivo. The generation of drugs sharing both antioxidant and carbonyl scavenger properties represents a new therapeutic challenge in the treatment of carbonyl stress‐associated diseases.British Journal of Pharmacology(2008)153, 6–20; doi:10.1038/sj.bjp.0707395; published online 23 July 2007